Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
2018 ◽
Vol 506
(1)
◽
pp. 27-32
Keyword(s):
Keyword(s):
2003 ◽
Vol 3
(1)
◽
pp. 1-3
◽
2004 ◽
Vol 100
(5)
◽
pp. 492-497
◽